Journey Medical Corp (DERM) support and resistance · rev $56.1M
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
This page maps Journey Medical Corp (DERM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported DERM revenue for 2024-12-31 was $56.1M. Net income was -$14.7M. Revenue was down 29.1% from 2023-12-31 to 2024-12-31. DERM currently screens at market cap $163.1M.
DERM currently screens at market cap $163.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new DERM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the DERM quote page for the session range and the stock page for the full model.
Not investment advice.